- Home
- TAYD vs APLT Comparison
TAYD vs APLT Comparison
Compare TAYD & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAYD
- APLT
- Stock Information
- Founded
- TAYD 1955
- APLT 2016
- Country
- TAYD United States
- APLT United States
- Employees
- TAYD N/A
- APLT N/A
- Industry
- TAYD Industrial Machinery/Components
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- TAYD Industrials
- APLT Health Care
- Exchange
- TAYD Nasdaq
- APLT Nasdaq
- Market Cap
- TAYD 150.7M
- APLT 140.8M
- IPO Year
- TAYD N/A
- APLT 2019
- Fundamental
- Price
- TAYD $42.99
- APLT $1.10
- Analyst Decision
- TAYD
- APLT Buy
- Analyst Count
- TAYD 0
- APLT 6
- Target Price
- TAYD N/A
- APLT $6.60
- AVG Volume (30 Days)
- TAYD 18.3K
- APLT 10.8M
- Earning Date
- TAYD 01-08-2025
- APLT 11-07-2024
- Dividend Yield
- TAYD N/A
- APLT N/A
- EPS Growth
- TAYD 44.55
- APLT N/A
- EPS
- TAYD 2.90
- APLT N/A
- Revenue
- TAYD $46,277,035.00
- APLT N/A
- Revenue This Year
- TAYD N/A
- APLT N/A
- Revenue Next Year
- TAYD N/A
- APLT $5,117.00
- P/E Ratio
- TAYD $15.04
- APLT N/A
- Revenue Growth
- TAYD 12.78
- APLT N/A
- 52 Week Low
- TAYD $21.99
- APLT $1.03
- 52 Week High
- TAYD $64.50
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- TAYD 40.94
- APLT 17.64
- Support Level
- TAYD $44.52
- APLT $1.03
- Resistance Level
- TAYD $46.51
- APLT $1.37
- Average True Range (ATR)
- TAYD 2.24
- APLT 0.33
- MACD
- TAYD -0.26
- APLT -0.15
- Stochastic Oscillator
- TAYD 7.45
- APLT 0.75
About TAYD Taylor Devices Inc.
Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.